SuperworthMapLight Therapeutics market cap MPLT
Share price times shares outstanding: what the whole company sells for, since 2025.
- Today, Oct 23, 2026
- $369.6M
- Highest close in our data
- $1.8B
- Jul 2026
MapLight Therapeutics is worth $369.6M at the close on Oct 23, 2026, at $7.97 a share.
That is down 56% over the last year.
Its highest close in our data was $1.8B in Jul 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $369.6M | $357.1M | $1.8B | −55% |
| 2025 | $817.2M | $817.2M | $939.2M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest MapLight Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| MPLTMapLight Therapeutics | $369.6M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| NATRNatures Sunshine Products | $213.8M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.2B |
| Peer median | $597.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on MapLight Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.